Corregene Biotechnology Co., Ltd: Clinical Trials

5 trials sponsored by Corregene Biotechnology Co., Ltd, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 2 not yet recruiting, 1 unknown. 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Active not recruiting 2, Not yet recruiting 2, Unknown 1

Follow Corregene Biotechnology Co., Ltd: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1 First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors
CRPA1A2 - Lung Cancer (Locally Advanced or Metastatic), Esophagus Cancer
Phase 1Not yet recruitingCorregene Biotechnology Co., Ltd1922026-05-292026-05-13
Treatment of Patients With Advanced Solid Tumors Using CRTKVA11-03 TCR-T Cell Injection
CRTKVA11-03 TCR-T Cell Injection - Advanced Solid Tumors
Phase 1Active not recruitingCorregene Biotechnology Co., Ltd62026-03-262026-09-17
KRAS-Specific Autologous TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors
KRAS-specific Autologous TCR-T cell injection - Colorectal, Pancreatic
Phase 1Active not recruitingCorregene Biotechnology Co., Ltd82025-02-182026-03-25
CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers
CRTE7A2-01 TCR-T cell therapy - Cervical Cancer, Anal Cancer
Phase 1Not yet recruitingCorregene Biotechnology Co., Ltd242024-04-152024-04-10
CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers
Fludarabine + Cyclophosphamide, Interleukin-2, CRTE7A2-01 TCR-T Cell - Cervical Cancer, Anal Cancer
Phase 1UnknownCorregene Biotechnology Co., Ltd122022-07-172022-06-28

Conditions studied

Head and Neck Neoplasms (3)  ·  Anus Neoplasms (2)  ·  Uterine Cervical Neoplasms (2)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Esophageal Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Neoplasm Metastasis (1)

Interventions

Cyclophosphamide (1)  ·  Interleukin-2 (1)  ·  fludarabine (1)

Countries

China (4)

Top investigators

Yang Xiang, Doctor (1)